Foghorn Therapeutics Inc logo

Foghorn Therapeutics Inc

NAS:FHTX (USA)   Ordinary Shares
$ 6.31 -0.36 (-5.45%) 11:09 PM EST
At Loss
Market Cap:
$ 349.12M
Enterprise V:
$ 202.04M
Volume:
76.71K
Avg Vol (2M):
119.48K
Trade In:
Volume:
76.71K
At Loss
Avg Vol (2M):
119.48K

Business Description

Foghorn Therapeutics Inc logo
Foghorn Therapeutics Inc
NAICS : 541714 SIC : 2833
ISIN : US3441741077

Share Class Description:

FHTX: Ordinary Shares
Description
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
Name Current Vs Industry Vs History
Cash-To-Debt 4.81
Equity-to-Asset -0.38
Debt-to-Equity -0.44
Debt-to-EBITDA -0.43
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.38
Distress
Grey
Safe
Beneish M-Score -1.57
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 55.42
9-Day RSI 56.69
14-Day RSI 55.69
6-1 Month Momentum % 73.86
12-1 Month Momentum % -35.52

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.06
Quick Ratio 4.06
Cash Ratio 3.97

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.7
Shareholder Yield % 1.79

Financials (Next Earnings Date:2024-08-02 Est.)

FHTX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:FHTX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Foghorn Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 33.896
EPS (TTM) ($) -2.2
Beta 3.44
Volatility % 180.25
14-Day RSI 55.69
14-Day ATR ($) 0.536581
20-Day SMA ($) 5.8185
12-1 Month Momentum % -35.52
52-Week Range ($) 2.7 - 9.97
Shares Outstanding (Mil) 55.33

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Foghorn Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Foghorn Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Foghorn Therapeutics Inc Frequently Asked Questions

What is Foghorn Therapeutics Inc(FHTX)'s stock price today?
The current price of FHTX is $6.31. The 52 week high of FHTX is $9.97 and 52 week low is $2.70.
When is next earnings date of Foghorn Therapeutics Inc(FHTX)?
The next earnings date of Foghorn Therapeutics Inc(FHTX) is 2024-08-02 Est..
Does Foghorn Therapeutics Inc(FHTX) pay dividends? If so, how much?
Foghorn Therapeutics Inc(FHTX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1